Prosetta Biosciences Stock

prosetta.comHealthcare / BioTech & PharmaFounded: 2003Funding to Date: $63.64MM

Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).

Register for Details

For more details on financing and valuation for Prosetta Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Prosetta Biosciences.

Register Today

Team

Management Team

Karl Manheim
Co-Founder & Board Member
Vishwanath Lingappa Ph.D
Co-Founder, Board Member, Chief Technology Officer & Chief Executive Officer
Thomas Higgins
Founding Chief Executive & Chairman

Board Members

CJ Sylvester
Fred Alger Management
Vishwanath Lingappa Ph.D
Dale Bredesen MD
Karl Manheim
Charles Parrish
David Keys
Thomas Higgins

Other companies like Prosetta Biosciences in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Purch Expands Industry-Leading Yield Optimization Platform
NEW YORK, March 28, 2017 /PRNewswire/ -- Purch, a digital publishing and marketplace platform, announced today that...
Updated on: Sep 20, 2023